- Home
- PMN vs AEON Comparison
PMN vs AEON Comparison
Compare PMN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- AEON
- Stock Information
- Founded
- PMN 2004
- AEON N/A
- Country
- PMN Canada
- AEON United States
- Employees
- PMN N/A
- AEON N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- PMN Health Care
- AEON Health Care
- Exchange
- PMN Nasdaq
- AEON Nasdaq
- Market Cap
- PMN 32.3M
- AEON 36.4M
- IPO Year
- PMN N/A
- AEON N/A
- Fundamental
- Price
- PMN $0.92
- AEON $0.63
- Analyst Decision
- PMN
- AEON Strong Buy
- Analyst Count
- PMN 0
- AEON 1
- Target Price
- PMN N/A
- AEON $5.00
- AVG Volume (30 Days)
- PMN 80.8K
- AEON 296.7K
- Earning Date
- PMN 12-31-2024
- AEON 11-13-2024
- Dividend Yield
- PMN N/A
- AEON N/A
- EPS Growth
- PMN N/A
- AEON N/A
- EPS
- PMN N/A
- AEON 0.34
- Revenue
- PMN N/A
- AEON N/A
- Revenue This Year
- PMN N/A
- AEON N/A
- Revenue Next Year
- PMN N/A
- AEON N/A
- P/E Ratio
- PMN N/A
- AEON $1.88
- Revenue Growth
- PMN N/A
- AEON N/A
- 52 Week Low
- PMN $0.87
- AEON $0.52
- 52 Week High
- PMN $3.10
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- PMN 45.09
- AEON 44.99
- Support Level
- PMN $0.87
- AEON $0.58
- Resistance Level
- PMN $0.94
- AEON $0.68
- Average True Range (ATR)
- PMN 0.07
- AEON 0.11
- MACD
- PMN -0.00
- AEON 0.01
- Stochastic Oscillator
- PMN 31.31
- AEON 16.54
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.